Secondary Iron Overload and the Liver: A Comprehensive Review
- PMID: 37408825
- PMCID: PMC10318281
- DOI: 10.14218/JCTH.2022.00420
Secondary Iron Overload and the Liver: A Comprehensive Review
Abstract
Iron overload is a condition involving excessive iron deposit in various organs, the liver being the main target organ for iron deposition and overload which are associated with significant liver morbidity and mortality. Iron overload can be categorized into primary and secondary causes. Primary iron overload, so-called hereditary hemochromatosis, is a well-recognized disease with available standard treatment recommendations. However, secondary iron overload is a more diverse disease with many unclear areas to be explored. Secondary iron overload is more prevalent than primary iron overload and occurs as a consequence of various causes which differ significantly across geographic regions. The main causes of secondary iron overload are iron-loading anemias, and chronic liver disease. The liver-related outcomes, patient outcomes, and treatment recommendations in these patients differ depending on the cause of iron overload. This review summarizes the causes, pathophysiology, liver-related outcomes, disease outcomes, and treatments of secondary iron overload.
Keywords: Cirrhosis; Hemochromatosis; Hepatocellular carcinoma; Iron overload; Thalassemia.
© 2023 Authors.
Conflict of interest statement
The authors have no conflict of interests related to this publication.
Figures


Similar articles
-
Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.Crit Rev Clin Lab Sci. 1983;19(3):205-66. doi: 10.3109/10408368309165764. Crit Rev Clin Lab Sci. 1983. PMID: 6373141 Review.
-
Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):767-778. doi: 10.1080/17474124.2018.1496016. Epub 2018 Jul 19. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29966105 Review.
-
Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.World J Gastroenterol. 2005 Feb 28;11(8):1241-4. doi: 10.3748/wjg.v11.i8.1241. World J Gastroenterol. 2005. PMID: 15754414 Free PMC article.
-
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):461-479. doi: 10.1016/s1499-3872(16)60135-2. Hepatobiliary Pancreat Dis Int. 2016. PMID: 27733315 Review.
-
The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample.Blood Sci. 2023 Jan 17;5(2):131-135. doi: 10.1097/BS9.0000000000000151. eCollection 2023 Apr. Blood Sci. 2023. PMID: 37228771 Free PMC article.
Cited by
-
Proteomics-Based Exploration of the Hepatoprotective Mechanism of α-Lipoic Acid in Rats with Iron Overload-Induced Liver Injury.Int J Mol Sci. 2025 May 16;26(10):4774. doi: 10.3390/ijms26104774. Int J Mol Sci. 2025. PMID: 40429916 Free PMC article.
-
Hemochromatosis-How Not to Overlook and Properly Manage "Iron People"-A Review.J Clin Med. 2024 Jun 23;13(13):3660. doi: 10.3390/jcm13133660. J Clin Med. 2024. PMID: 38999226 Free PMC article. Review.
-
The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies.Rev Recent Clin Trials. 2024;19(4):242-255. doi: 10.2174/0115748871305325240511122602. Rev Recent Clin Trials. 2024. PMID: 38818907
-
Magnetic sculpture-like tumor cell vaccines enable targeted in situ immune activation and potent antitumor effects.Theranostics. 2025 Apr 13;15(11):5358-5380. doi: 10.7150/thno.107162. eCollection 2025. Theranostics. 2025. PMID: 40303352 Free PMC article.
-
Impact of body fat composition on liver iron overload severity in hemochromatosis: a retrospective MRI analysis.Radiol Med. 2025 Feb;130(2):179-189. doi: 10.1007/s11547-024-01930-8. Epub 2024 Nov 22. Radiol Med. 2025. PMID: 39578337 Free PMC article.
References
-
- Acton RT, Barton JC, Snively BM, McLaren CE, Adams PC, Harris EL, et al. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis. 2006;16(4):815–821. - PubMed
Publication types
LinkOut - more resources
Full Text Sources